Paragon 28, Inc. (FNA)

USD 10.04

(-3.09%)

Operating Expenses Summary of Paragon 28, Inc.

  • Paragon 28, Inc.'s latest annual operating expenses in 2023 was 210.1 Million USD , up 5.75% from previous year.
  • Paragon 28, Inc.'s latest quarterly operating expenses in 2024 Q2 was 51.91 Million USD , down -8.54% from previous quarter.
  • Paragon 28, Inc. reported a annual operating expenses of 183.97 Million USD in annual operating expenses 2022, up 41.28% from previous year.
  • Paragon 28, Inc. reported a annual operating expenses of 130.21 Million USD in annual operating expenses 2021, up 55.37% from previous year.
  • Paragon 28, Inc. reported a quarterly operating expenses of 61.79 Million USD for 2024 Q1, up 20.21% from previous quarter.
  • Paragon 28, Inc. reported a quarterly operating expenses of 51.37 Million USD for 2023 Q3, down -0.27% from previous quarter.

Annual Operating Expenses Chart of Paragon 28, Inc. (2023 - 2019)

Historical Annual Operating Expenses of Paragon 28, Inc. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 210.1 Million USD 5.75%
2022 183.97 Million USD 41.28%
2021 130.21 Million USD 55.37%
2020 83.81 Million USD -1.09%
2019 84.73 Million USD 0.0%

Peer Operating Expenses Comparison of Paragon 28, Inc.

Name Operating Expenses Operating Expenses Difference
Abbott Laboratories 15.71 Billion USD 98.663%
Allurion Technologies Inc. 120.57 Million USD -74.248%
Artivion, Inc. 223.43 Million USD 5.968%
Avanos Medical, Inc. 375.5 Million USD 44.048%
Butterfly Network, Inc. 162.46 Million USD -29.319%
Butterfly Network, Inc. 162.46 Million USD -29.319%
Bio-Rad Laboratories, Inc. 1.04 Billion USD 79.944%
Boston Scientific Corporation 7.47 Billion USD 97.19%
Perspective Therapeutics, Inc. 17.42 Million USD -1105.67%
CONMED Corporation 564.24 Million USD 62.764%
Edwards Lifesciences Corporation 3.09 Billion USD 93.203%
Glaukos Corporation 367.83 Million USD 42.882%
Globus Medical, Inc. 887.16 Million USD 76.318%
Inspire Medical Systems, Inc. 568.49 Million USD 63.043%
Integer Holdings Corporation 250.95 Million USD 16.281%
Medtronic plc 16.12 Billion USD 98.697%
Nevro Corp. 389.36 Million USD 46.041%
Owlet, Inc. 51.21 Million USD -310.199%
Penumbra, Inc. 590.87 Million USD 64.443%
Vicarious Surgical Inc. 80.66 Million USD -160.457%
Smith & Nephew plc 3.46 Billion USD 93.94%
Sonendo, Inc. 68.46 Million USD -206.872%
STERIS plc 1.4 Billion USD 84.997%
Stryker Corporation 9.2 Billion USD 97.719%
Vapotherm, Inc. 66.02 Million USD -218.213%
Zimmer Biomet Holdings, Inc. 3.27 Billion USD 93.587%